Samir N Khleif Selected Research

Samir N Khleif Research Topics

Disease

49	Neoplasms (Cancer) 01/2023 - 01/2006
6	Melanoma (Melanoma, Malignant) 01/2022 - 01/2015
3	Disease Progression 02/2020 - 01/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2010
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2014 - 04/2003
2	Ovarian Neoplasms (Ovarian Cancer) 08/2014 - 03/2012
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	COVID-19 01/2021
1	Endometrial Neoplasms (Endometrial Cancer) 02/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Hypersensitivity (Allergy) 09/2014
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 08/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2011
1	Papillomavirus Infections 08/2009
1	Infections 08/2009
1	Colorectal Neoplasms (Colorectal Cancer) 09/2008
1	Pain (Aches) 05/2007

Drug/Important Bio-Agent (IBA)

16	VaccinesIBA 01/2022 - 06/2006
12	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2008
7	AntigensIBA 01/2022 - 06/2009
6	Protein Subunit VaccinesIBA 01/2022 - 08/2007
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2009
6	Peptides (Polypeptides)IBA 12/2014 - 01/2006
4	LigandsIBA 01/2022 - 01/2013
4	AntibodiesIBA 01/2020 - 06/2006
4	Cancer VaccinesIBA 11/2015 - 01/2010
2	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2020
2	EnzymesIBA 01/2022 - 01/2018
2	pembrolizumabIBA 01/2021 - 01/2015
2	NivolumabIBA 01/2021 - 01/2015
2	durvalumabIBA 10/2019 - 01/2019
2	Tumor Biomarkers (Tumor Markers)IBA 12/2018 - 07/2010
2	Interleukin-2 (IL2)IBA 02/2014 - 08/2007
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2014 - 08/2007
1	PyrrolesIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Immunomodulating AgentsIBA 12/2021
1	copanlisibIBA 02/2020
1	Monoclonal AntibodiesIBA 10/2019
1	Immunoglobulins (Immunoglobulin)IBA 10/2019
1	Tryptophan (L-Tryptophan)FDA Link 01/2018
1	KynurenineIBA 01/2018
1	1-methyltryptophanIBA 01/2018
1	navoximodIBA 01/2018
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2017
1	GlucocorticoidsIBA 01/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2016
1	Interleukin-10 (Interleukin 10)IBA 04/2016
1	IpilimumabIBA 01/2015
1	Listeria monocytogenes hlyA protein (listeriolysin O)IBA 09/2014
1	Mutant Proteins (Protein, Mutant)IBA 02/2014
1	Death Domain ReceptorsIBA 09/2012
1	pidilizumabIBA 10/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2010
1	Monatide (IMS 3015)IBA 01/2010
1	Viral ProteinsIBA 08/2009
1	InterferonsIBA 06/2009
1	Therapeutic UsesIBA 08/2007
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2006
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2006

Therapy/Procedure

27	Immunotherapy 01/2023 - 01/2006
14	Therapeutics 01/2023 - 04/2003
3	Biological Therapy 12/2010 - 12/2008
2	Drug Therapy (Chemotherapy) 01/2020 - 05/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023
1	Subcutaneous Injections 03/2012
1	Chemoprevention 03/2011
1	Palliative Care (Palliative Therapy) 05/2007